Evidence
What the research shows
TB-500 is the synthetic version of thymosin beta-4, a naturally occurring peptide found in all human and animal cells and closely associated with tissue repair signaling. The current evidence base is strongest in preclinical research, where thymosin beta-4 has shown systemic tissue-repair, anti-inflammatory, and angiogenic effects rather than purely local action. Small human studies add early translational support, but this is not yet a large-RCT compound on the level of approved therapeutics. That honesty matters: TB-500 is compelling because the biology is broad, the recovery use case is intuitive, and the animal data consistently points in the same direction. Interest keeps accelerating because it is one of the few research peptides positioned for whole-body recovery support instead of a single narrow pathway.